Complete Up To Date Information about Tresaderm Dermatologic Solution.
NADA Number: 042-633 | |
| Proprietary Name |
Tresaderm Dermatologic Solution |
|---|---|
| Sponsor |
Merial Ltd. |
| Sponsor Address |
3239 Satellite Blvd. Bldg. 500 Duluth, GA 30096-4640 USA |
| Ingredients |
Dexamethasone Neomycin Sulfate Thiabendazole |
| Species |
Cat, no use class stated or implied Dog, no use class stated or implied |
| Routes of Administration |
Topical |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
524.1484g Neomycin sulfate-thiabendazole-dexamethasone solution. Specifications: Each cubic centimeter of neomycin sulfate-thiabendazole-dexamethasone solution contains: 40 milligrams of thiabendazole, 3.2 milligrams of neomycin (from neomycin sulfate), and 1 milligram of dexamethasone. Conditions of use: Dogs Amount: In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration. Indications: The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs. Limitations: For use only by or on order of a licensed veterinarian. Cats Amount: In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration. Indications: The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in cats. Limitations: For use only by or on order of a licensed veterinarian. |
| Tolerances |
Tolerances are established for residues of parent neomycin in uncooked edible tissues as follows: a. In cattle, swine, sheep, and goats: 7.2 parts per million in kidney (target tissue) and fat, 3.6 ppm in liver, and 1.2 ppm in muscle. b. In turkeys: 7.2 ppm in skin with adhering fat, 3.6 parts per million in liver, and 1.2 ppm in muscle. c. In milk: 0.15 part per million. Tolerances are established as follows: a. Cattle, goats, sheep, pheasants, and swine: 0.1 part per million for negligible residues of thiabendazole in uncooked edible tissues b. Milk: 0.05 part per million for negligible residues |